Lexington Facility Will Boost Cancer Drug Supply
Piramal Pharma Solutions and NP2 expect to complete the development of sterile injectable cyclophosphamide by 2026.
Live Poll
Do you believe domestic manufacturing of essential drugs is necessary to prevent medication shortages?